These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16847431)

  • 1. TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis.
    Loos T; Dekeyzer L; Struyf S; Schutyser E; Gijsbers K; Gouwy M; Fraeyman A; Put W; Ronsse I; Grillet B; Opdenakker G; Van Damme J; Proost P
    Lab Invest; 2006 Sep; 86(9):902-16. PubMed ID: 16847431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids.
    Proost P; Verpoest S; Van de Borne K; Schutyser E; Struyf S; Put W; Ronsse I; Grillet B; Opdenakker G; Van Damme J
    J Leukoc Biol; 2004 May; 75(5):777-84. PubMed ID: 14996826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies.
    Proost P; Struyf S; Loos T; Gouwy M; Schutyser E; Conings R; Ronsse I; Parmentier M; Grillet B; Opdenakker G; Balzarini J; Van Damme J
    Arthritis Res Ther; 2006; 8(4):R107. PubMed ID: 16846531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The production of CXCR3-agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritis.
    Ueno A; Yamamura M; Iwahashi M; Okamoto A; Aita T; Ogawa N; Makino H
    Rheumatol Int; 2005 Jun; 25(5):361-7. PubMed ID: 15004722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial Toll-like receptor ligands differentially regulate CXCL10/IP-10 expression in fibroblasts and mononuclear leukocytes in synergy with IFN-gamma and provide a mechanism for enhanced synovial chemokine levels in septic arthritis.
    Proost P; Vynckier AK; Mahieu F; Put W; Grillet B; Struyf S; Wuyts A; Opdenakker G; Van Damme J
    Eur J Immunol; 2003 Nov; 33(11):3146-53. PubMed ID: 14579283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
    Antonelli A; Ferrari SM; Giuggioli D; Ferrannini E; Ferri C; Fallahi P
    Autoimmun Rev; 2014 Mar; 13(3):272-80. PubMed ID: 24189283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection.
    Meyer M; Hensbergen PJ; van der Raaij-Helmer EM; Brandacher G; Margreiter R; Heufler C; Koch F; Narumi S; Werner ER; Colvin R; Luster AD; Tensen CP; Werner-Felmayer G
    Eur J Immunol; 2001 Aug; 31(8):2521-7. PubMed ID: 11500837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11).
    Sauty A; Colvin RA; Wagner L; Rochat S; Spertini F; Luster AD
    J Immunol; 2001 Dec; 167(12):7084-93. PubMed ID: 11739530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands.
    Pierer M; Rethage J; Seibl R; Lauener R; Brentano F; Wagner U; Hantzschel H; Michel BA; Gay RE; Gay S; Kyburz D
    J Immunol; 2004 Jan; 172(2):1256-65. PubMed ID: 14707104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes.
    Kanda N; Watanabe S
    Endocrinology; 2007 May; 148(5):2317-25. PubMed ID: 17255201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
    Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
    Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of plasma cells expressing CXCR3 in the synovial sublining regions of early rheumatoid arthritis in association with production of Mig/CXCL9 by synovial fibroblasts.
    Tsubaki T; Takegawa S; Hanamoto H; Arita N; Kamogawa J; Yamamoto H; Takubo N; Nakata S; Yamada K; Yamamoto S; Yoshie O; Nose M
    Clin Exp Immunol; 2005 Aug; 141(2):363-71. PubMed ID: 15996201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes.
    Kanda N; Shimizu T; Tada Y; Watanabe S
    Eur J Immunol; 2007 Feb; 37(2):338-50. PubMed ID: 17274000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of cysteine-X-cysteine motif chemokine ligands 9, 10, and 11, their receptor CXCR3, and their possible role on the recruitment of immune cells at the maternal-conceptus interface in pigs.
    Han J; Gu MJ; Yoo I; Choi Y; Jang H; Kim M; Yun CH; Ka H
    Biol Reprod; 2017 Jul; 97(1):69-80. PubMed ID: 28859287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9.
    Lebre MC; van der Aar AM; van Baarsen L; van Capel TM; Schuitemaker JH; Kapsenberg ML; de Jong EC
    J Invest Dermatol; 2007 Feb; 127(2):331-41. PubMed ID: 17068485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-gamma-inducible T cell alpha chemoattractant is a potent stimulator of normal human blood T lymphocyte transendothelial migration: differential regulation by IFN-gamma and TNF-alpha.
    Mohan K; Ding Z; Hanly J; Issekutz TB
    J Immunol; 2002 Jun; 168(12):6420-8. PubMed ID: 12055261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production.
    Whiting D; Hsieh G; Yun JJ; Banerji A; Yao W; Fishbein MC; Belperio J; Strieter RM; Bonavida B; Ardehali A
    J Immunol; 2004 Jun; 172(12):7417-24. PubMed ID: 15187119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the pleiotropic actions of the IFN-inducible CXC chemokine receptor 3 ligands in the synovial microenvironment.
    Dillemans L; De Somer L; Neerinckx B; Proost P
    Cell Mol Life Sci; 2023 Mar; 80(3):78. PubMed ID: 36862204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
    Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
    J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin displaces interferon-gamma-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells.
    Ranjbaran H; Wang Y; Manes TD; Yakimov AO; Akhtar S; Kluger MS; Pober JS; Tellides G
    Circulation; 2006 Sep; 114(12):1293-300. PubMed ID: 16940188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.